Emergency Management of Malignancy-Associated Hypercalcemia.
Dellay B, Groth M.
Adv Emerg Nurs J. 2016 Jan-Mar;38(1):15-25; quiz E1. doi: 10.1097/TME.0000000000000093.
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.
O'Callaghan S, Yau H.
Endocr Connect. 2021 Jan;10(1):R13-R24. doi: 10.1530/EC-20-0487.
Hypercalcemia of malignancy.
Insogna KL, Broadus AE.
Annu Rev Med. 1987;38:241-56. doi: 10.1146/annurev.me.38.020187.001325.
[Treatment of malignancy associated hypercalcemia].
Tai N, Inoue D.
Clin Calcium. 2014 Aug;24(8):1223-8.
Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH, Dalkin AC.
Clin J Am Soc Nephrol. 2012 Oct;7(10):1722-9. doi: 10.2215/CJN.02470312. Epub 2012 Aug 9.
[Malignancy-associated hypercalcemia].
Yamaguchi K.
Gan To Kagaku Ryoho. 1991 Mar;18(3):343-9.
Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA.
Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):339-46. doi: 10.1097/MED.0b013e32834b4401.
Malignant hypercalcemia.
Basso U, Maruzzo M, Roma A, Camozzi V, Luisetto G, Lumachi F.
Curr Med Chem. 2011;18(23):3462-7. doi: 10.2174/092986711796642490.
Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K, Onuma E, Yocum RC, Ogata E.
Semin Oncol. 2003 Oct;30(5 Suppl 16):167-73. doi: 10.1053/j.seminoncol.2003.08.019.
Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer.
Szymanski JJ, Otrock ZK, Patel KK, Scott MG.
Clin Chim Acta. 2016 Jan 30;453:190-3. doi: 10.1016/j.cca.2015.12.017. Epub 2015 Dec 17.
